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MBF Quantification With
82 Rb PET cardial blood flow (MBF). 13, 14 Hajjiri et al reported that MBF quantification had better diagnostic accuracy than did relative perfusion uptake using 13 N-ammonia PET. 15 We demonstrated that regional MBF quantification had an additional diagnostic value over 99m Tc tetrofosmin SPECT MPI using 15 O-water PET. 16 In most previous studies, MBF measurements using PET have been performed using either 15 O-water or 13 N-ammonia, which requires immediate access to an on-site cyclotron. 13, 14 This requirement is a major limitation of PET MBF quantification and makes it difficult to evaluate myocardial ischemia or risk in larger populations. 82 Rb is a PET perfusion tracer produced from a strontium-82 ( 82 Sr)/ 82 Rb generator. 17 In North America, 82 Rb is widely used in PET centers without immediate access to a cyclotron for the diagnosis of CAD. 11, 14 Recently, some centers in Japan and Europe have started using 82 Rb. 17, 18 However, there are still limited data reported on MBF quantification using 82 Rb. 18- 23 Parkash et al, using a net retention model for MBF quantification and examining perfusion in the left ventricle (LV) as a whole, suggested that the results were more severe than those determined using a standard uptake approach to evaluate regional MBF. 24 However, they used the net retention model for MBF quantification, which is an approach that has higher statistical noise and is considered to be less accurate than a compartmental model. Moreover, they evaluated only global LV MBF and did not evaluate regional MBF. To our knowledge, no data evaluating the additional value of regional MBF quantification over relative perfusion imaging using 82 Rb PET have been published. The purpose of the current study was to evaluate the additional diagnostic value of regional MBF quantification over that of relative perfusion imaging in segments with and without ischemia using 82 Rb PET in patients with known or suspected CAD.
Methods
Study Population
Patients with known or suspected CAD, whose condition was stable and who did not undergo coronary revascularization or have a myocardial infarction within 4 weeks prior to the study (n=12) were followed prospectively between August 2007 and September 2009. Exclusion criteria were previous myocardial infarction and severe obstructive lung disease. This study was approved by the Hokkaido University Graduate School of Medicine Human Research Ethics Board. Written informed consent was given by all subjects.
Study Protocol
The study population underwent CAG and 82 Rb PET imaging within 8 weeks (mean interval 11.5±13.4 days, range 1-49 days). All subjects were in a stable clinical condition between the 82 Rb PET and angiographic procedures.
PET Acquisition Protocol
Patients were instructed to fast for >6 h and to abstain from caffeine-containing products for >24 h before the PET studies. 16,25, 26 Participants were positioned with the heart centered in the field of view of a whole-body PET scanner (ECAT HR+, Siemens/CTI Knoxville, TN, USA). All emission and transmission scans were performed in the 2-D acquisition mode.
Immediately following the 5-min transmission scan, 1,480 MBq of 82 Rb (Bracco Diagnosis, Princeton, NJ, USA or DRAXIMAGE, Kirkland, QC, Canada) was administered intravenously over 1 min. 18,27 A 10-min, 17-frame dynamic acquisition was initiated (12×10 s, 2×30 s, 1×60 s, 1×120 s, 1× 240 s). 18,21,27,28 Then, 10 min later, we repeated the same sequence of dynamic acquisition during adenosine triphosphate (ATP) induced hyperemia. ATP (160 μg · kg -1 · min -1 ) was infused intravenously for 9 min, and image acquisition was started 3 min after the start of the ATP infusion. 18, 29 During the ATP stress, symptoms, heart rate, blood pressure, and the ECG were continuously monitored.
Image Processing
Dynamic image data were reconstructed using filtered backprojection reconstruction with a 12-mm Hann filter with randoms, scatter, attenuation and decay corrections. Each image consisted of 63 transaxial slices, each having 128×128 voxels with dimensions 3.4×3.4×2.4 mm. A myocardial uptake image was generated by summing the last 4-6 min of the image sequence. A blood volume image was created by summing the first 2 min of the image sequence. The images were reoriented and segmented semi-automatically to generate LV blood and myocardial time -activity curves (TACs).
Standard Relative Perfusion Image Interpretation
Two experienced observers blinded to all clinical data reviewed each rest and pharmacological stress myocardial perfusion image. A consensus was reached in cases where there were differences in observations. Regional relative myocardial perfusion was assessed using the 17-segment model. The semiquantitative scoring system of defect severity used a 5-point scale (0 = normal to 4 = absent uptake) as recommended by American Society of Nuclear Cardiology (ASNC). 30 Summed difference scores ≥2 were considered to indicate the presence of myocardial ischemia. 28, 30 Regional perfusion abnormalities were assigned to a coronary arterial territory based on ASNC imaging guidelines. 30 
Quantification of MBF
Regional MBF quantification was performed using a software program developed in-house. 18 This software semi-automatically defines regions of interest (ROIs) for the LV cavity blood pool and the LV myocardium. 31 The LV wall is divided into 16 segments 32 and grouped into 3 coronary artery territories. 16 The program then performs segmental MBF quantification using a 1-tissue-compartment tracer kinetic model 21,31 as follows.
The segmental ROIs were applied to the dynamic image sequence to generate LV blood and myocardium TACs, LV(t) and R(t), respectively. The myocardium was modeled as a partial volume mixture of arterial blood, Ca(t), and tissue, Ct(t), activity concentrations as in Equation 1 where PTF denotes perfusable tissue fraction. Va is the arterial blood volume, and ρ is the density of tissue (1.04 g/ml).
The change in myocardial activity concentration was modeled using the 1-tissue-compartment model in Equation 2, where K1 (ml · min -1 · g -1 ) is the uptake rate from blood into the tissue and k2 (/min) is the washout rate from myocardial tissue into the blood Ca(t) (Bq/ml).
The LV blood activity concentration was modeled as a partial volume mixture of β=85% arterial blood and (1-β=15%) tissue, as shown in Equation 3 .
Equations 1-3 were used to estimate the parameters K1, k2, PTF, Va with a non-linear least-squares analysis. Conversion YOSHINAGA K et al. 
The baseline MBF is closely related to the rate -pressure product (RPP). Thus, rest MBF results were corrected for the RPP as rest MBF × (normal mean RPP/individual RPP). 16, 18 The normal mean RPP at rest in our institution was 8,150. 18 RPP-corrected coronary flow reserve (CFR) was calculated as the ratio of MBF during hyperemia to RPP-corrected rest MBF. 16,18 CAG All patients underwent CAG using a standard technique. Two experienced investigators blinded to the clinical and 82 Rb PET data analyzed the CAG data. The angiographic criterion used to define the significant coronary stenosis was defined as >70% decrease in diameter for the 3 major coronary arteries or their major branches using quantitative coronary analysis (QCA). 12 
Segmentation Classifications
Using QCA data and relative 82 Rb relative perfusion images, the LV segments were classified into 4 groups (Group A: myocardial ischemia with >70% diameter stenosis; Group B: no ischemia with stenosis; Group C: no ischemia without stenosis; Group D: ischemia without stenosis).
Statistical Analysis
Continuous variables are presented as means and standard deviations. Categorical variables are presented as frequencies with percentages. The 82 Rb PET-derived parameters (MBF and CFR) were compared among the 4 groups using repeated-measures analysis of variance (ANOVA), with the Scheffé F test applied when ANOVA results were statistically significant. The correlations between coronary arterial stenosis and hyperemic MBF and CFR were assessed using Spearman's linear regression analysis. A P-value<0.05 was considered statistically significant. Statistical calculations were carried out using SAS software (SAS Institute, Inc, Cary, NC, USA).
Results
Patients' Characteristics
The 12 consecutive patients (mean age, 70.8±10.2 years, 6 men) underwent 82 Rb PET and CAG (Table 1); 9 patients had known CAD and 3 patients had suspected CAD. The mean time interval between 82 Rb PET and CAG was 11.5±13.4 days (range 1-49 days). In total, 10 of the 12 patients (83%) had multivessel coronary stenosis. 
Hemodynamics During ATP Stress
The ATP stress was well tolerated by all participants. Two patients had ischemic changes on ECG and 2 patients had chest pain during ATP stress. ATP stress significantly increased heart rate and tended to increase RPP with the 82 Rb PET studies ( Table 2) .
Rest MBF and MBF During ATP Stress
Rest MBF was similar among the 4 groups ( Table 3 ). The MBF of Group A segments (n=14) and Group D segments (n= 2) did not increase during hyperemia as compared with MBF at rest (Figures 1,2 ; Table 3 ). In Group B (n=10) and Group C (n=10) segments, there were significant MBF increases during hyperemia as compared with MBF at rest. Group A segments and Group B segments showed reduced hyperemic MBF compared with that for Group C segments (P<0.05) (Figure 2) . Groups A and B also showed reduced CFR compared with that for Group C (P<0.05) (Figure 3) . There was no significant difference between Group A and Group B segments for either hyperemic MBF or CFR.
Correlations Between 82 Rb Measurements and Coronary Stenosis
Hyperemic MBF (r=-0.76, P<0.0001) and CFR (r=-0.76, P< 0.0001) inversely correlated with percent diameter stenosis on quantitative CAG (Figure 4) .
Discussion
Hyperemic MBF and CFR inversely correlated with percent coronary artery diameter stenosis on quantitative CAG. Segments with reversible ischemia and coronary stenosis had reduced hyperemic MBF. Even segments that had significant coronary stenosis, but were negative for ischemia, had reduced hyperemic MBF compared with that for non-stenotic segments. Thus, MBF quantification by 82 Rb PET may provide additional diagnostic information over that obtained through standard visual analysis in patients with CAD.
MBF Measurements Using 82 Rb PET
Quantitative MBF measurements using 82 Rb PET have been validated through the use of other PET flow tracers 21 and animal models. 33 Lortie et al reported that 82 Rb MBF measurements at rest and during pharmacological stress correlated with those for 13 N-ammonia PET in humans. 21 Manabe et al showed good repeatability of 82 Rb MBF measurements during stress and at rest. 18 Thus, 82 Rb MBF measurements may be useful in the clinical setting for the diagnosis of CAD in patients.
In the present study, segmental rest MBF ranged from 0.89 to 1.09 ml · min -1 · g -1 among the 4 groups. These rest MBF values were similar to typical rest MBF values obtained through standard approaches using 15 O-water or 13 N-ammonia PET. 13, 14 Hyperemic MBF in the segments without coronary stenosis was more than 2.5 ml · min -1 · g -1 . In contrast, hyperemic MBF in the segments with coronary stenosis was less than 2.0 ml · min -1 · g -1 . A CFR ≥2.0 is generally considered normal 13 and is associated with a low risk of cardiovascular events. Therefore, the current MBF measurements are considered to be accurate. Moreover, the hyperemic MBF and CFR inversely correlated with percent diameter stenosis on QCA, which is in agreement with previously reported findings. 34
Additional Diagnostic Value of MBF Quantification Over Relative Perfusion Imaging
Our group previously reported that MBF quantification using 15 O-water PET provided additional diagnostic value over SPECT MPI. 16 Herzog et al reported that CFR also had longterm prognostic value. 35 Myocardial perfusion PET has higher diagnostic accuracy than does SPECT. 6,9,36 However, even when using PET, relative perfusion imaging still has limited ability to detect myocardial ischemia, especially in cases of multivessel disease. 12 Thus, routine MBF quantification has been sought for clinical application. 37 15 O-water and 13 N-ammonia require immediate access to an on-site cyclotron and therefore these PET flow tracers have not seen wide clinical usage. In contrast, 82 Rb is a generatorproduced PET flow tracer and has been widely used in clinical settings in North America. 10,17, 23 The additional diagnostic value of MBF quantification using 82 Rb has been predicted, 17,38 but to date supporting data have been limited. Parkash et al showed the additional diagnostic value of 82 Rb MBF quantification in patients with 3-vessel CAD. 24 However, they evaluated MBF using a retention index, which has high statistical noise and is now considered a less accurate approach. Moreover, they evaluated a reduced MBF in the whole LV and did not evaluate regional MBF. In the present study, we used a single-tissue compartment model for MBF quantification, which a standard and accurate approach. 31 In fact, previous studies showed that the repeatability of MBF measurements using this approach is excellent. 18 In the clinical setting, it is important to detect critical coronary stenosis not only for diagnosis but also with regard to performing coronary intervention. Therefore, the current data may provide additional insight over that obtained through previous studies and thus contribute to CAD patient care.
Study Limitations
First, the sample size of the present study was small. 82 Rb is produced from a strontium-82 ( 82 Sr)/ 82 Rb generator in the United States and Canada, but there is no radiopharmaceutical company that provides this generator in Japan. Thus, it is very difficult to perform additional 82 Rb PET studies in our facility. Moreover, current radioisotope providers guarantee the quality of the generator for only 4-8 weeks. Sufficient 82 Rb radioactivity can be obtained for clinical imaging within this period only. Thus, study duration was quite limited in our facility, and we do not currently have a usable 82 Rb generator. Thus, it is not possible to perform additional data acquisition and to increase the study population. However, the current data clearly showed differences between hyperemic MBF and CFR among the regions with a range of disease severity (Groups A, B, and C). Although the findings from the present study were sufficient to detect significant differences, further studies involving a larger cohort or more centers are required to confirm our results and support the wider use of this approach in Japan.
Second, this study aimed to show the diagnostic value of 82 Rb MBF quantification and did not have long-term follow-up data. Further study is required to determine the additional prognostic value of 82 Rb MBF quantification.
Third, the number of segments in Group D (abnormal perfusion without coronary stenosis) was small, so it was not possible to evaluate the clinical role of this group based on the present data. However, a larger sample size may show that this type of segment has clinical meaning. Previous reports have shown that this pattern is associated with early vascular dysfunction. CFR was reduced in myocardium subtended by normal coronary arteries in patients with CAD. 16, 39 The magnitude of CFR reduction was lower than that in segments supplied by stenotic coronary arteries. Because relative perfusion images depend on blood flow distribution, this small vasodilator capacity reduction may (sometimes) induce perfusion abnormalities. Herzog et al reported that perfusion defects and reduced CFR were independently associated with cardiovascular events. 35 Although the population of Group D was small, the current data showed reduced CFR in Group D compared to that in Group C (no stenosis without ischemia), consistent with previous reports. Thus, this finding of abnormal CFR may be associated with an increased risk of cardiac events. Further investigation is required to evaluate such a possibility.
Conclusions
In the present study, hyperemic MBF and CFR measured by 82 Rb PET inversely correlated with percent diameter stenosis on quantitative CAG. Segments with reversible ischemia and coronary stenosis had reduced hyperemic MBF. Even segments with coronary stenosis, but normal stress perfusion, had reduced hyperemic MBF compared with that of non-stenotic segments. Thus, MBF quantification by 82 Rb PET may provide additional diagnostic information over that obtained through standard visual analysis in patients with CAD.
